Furthermore, c-Myc was shown to function as a pro-proliferative and anti-apoptotic factor in RMS by repressing p21, and when it was depleted in ERMS cell lines a number of metastatic, invasive and angiogenic markers decreased [42,48,49]. The gene discussed is MYC; the disease is embryonal rhabdomyosarcoma.